Dashboard
Manage Tickers

KALA KALA BIO, Inc.

Nasdaq kalarx.com


$ 0.77 $ -0.02 (-2.35 %)    

Monday, 03-Nov-2025 18:09:45 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 623.81 $ 0.00 (0 %)
DIA $ 469.97 $ 0.00 (0 %)
SPY $ 676.40 $ 0.00 (0 %)
TLT $ 89.92 $ 0.00 (0 %)
GLD $ 367.39 $ 0.00 (0 %)
$ 0.7617
$ 0.80
$ 0.76 x 100
$ 0.84 x 100
-- - --
$ 0.74 - $ 20.60
154,057
na
5.35M
$ 0.03
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-29-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-04-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-03-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-29-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-05-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-12-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-12-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 04-02-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-31-2017 06-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
10/31/2025 21:07:54

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/20/2025 18:39:30

kala-bio-terminates-ceo-todd-bazemore-without-cause-oxford-to-foreclose-on-all-kala-bios-remaining-assets-co-terminates-all-remaining-employees-for-foreclosure-co-owes-oxford-about-96m
KALA BIO Terminates CEO Todd Bazemore With...
10/20/2025 12:15:07

- SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/20/2025 12:08:17

on-sep-29-kala-bio-receives-notice-of-event-of-default-from-oxford-finance-total-obligations-declared-payable-is-291m
On Sep 29, Kala Bio Receives Notice Of Eve...
10/01/2025 13:36:09

-SEC Filing

crude-oil-falls-sharply-carnival-posts-upbeat-earnings
Crude Oil Falls Sharply; Carnival Posts Up...
09/29/2025 17:14:55

U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Monday. The Dow traded do...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
09/29/2025 17:06:50

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

why-is-eye-disease-focused-kala-bio-stock-plunging-on-monday
Why Is Eye Disease Focused Kala Bio Stock ...
09/29/2025 16:00:06

Kala Bio Inc. (NASDAQ: KALA) stock is down on Monday after the company halted development of its experimental treatment for a s...

kala-bio-shares-resume-trade
KALA BIO Shares Resume Trade
09/29/2025 15:03:17

kala-bio-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--8882
KALA BIO Shares Halted On Circuit Breaker ...
09/29/2025 14:58:19

kala-bio-shares-halted-stock-now-down--8766
KALA BIO Shares Halted, Stock Now Down -87...
09/29/2025 14:53:04

kala-bio-shares-resume-trade-following-circuit-breaker-halt
KALA BIO Shares Resume Trade Following Cir...
09/29/2025 14:52:02

nasdaq-jumps-150-points-us-pending-home-sales-rise
Nasdaq Jumps 150 Points; US Pending Home S...
09/29/2025 14:11:58

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market ...

kala-bio-shares-halted-on-code-news-pending
KALA BIO Shares Halted On Code News Pending
09/29/2025 12:14:29

kala-bio-chase-phase-2b-clinical-trial-of-kpi-012-for-persistent-corneal-epithelial-defect-did-not-meet-primary-endpoint
KALA BIO CHASE Phase 2b Clinical Trial Of ...
09/29/2025 12:02:33

trading-halt-halted-at-75500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:55:00 a.m. ET - ...
09/29/2025 11:55:04

hc-wainwright--co-maintains-buy-on-kala-bio-raises-price-target-to-35
HC Wainwright & Co. Maintains Buy on Kala ...
09/17/2025 10:34:25

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and raises the price target from $12 to ...

oppenheimer-maintains-outperform-on-kala-bio-raises-price-target-to-33
Oppenheimer Maintains Outperform on Kala B...
09/11/2025 13:29:40

Oppenheimer analyst Andreas Argyrides maintains Kala Bio (NASDAQ:KALA) with a Outperform and raises the price target from $1...

mizuho-initiates-coverage-on-kala-bio-with-outperform-rating-announces-price-target-of-30
Mizuho Initiates Coverage On Kala Bio with...
09/08/2025 11:42:50

Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio (NASDAQ:KALA) with a Outperform rating and announces Price T...

kala-bio-names-todd-bazemore-as-president-chief-executive-officer-and-director
KALA BIO Names Todd Bazemore as President,...
09/02/2025 12:12:17

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION